tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Arvinas and Pfizer Submit New Drug Application
PremiumCompany AnnouncementsArvinas and Pfizer Submit New Drug Application
2M ago
Arvinas announces submission of NDA to FDA for vepdegestrant
Premium
The Fly
Arvinas announces submission of NDA to FDA for vepdegestrant
2M ago
Positive Buy Rating for Arvinas Holding Company Driven by Promising VERITAC-2 Trial Results and Strategic Partnership with Pfizer
Premium
Ratings
Positive Buy Rating for Arvinas Holding Company Driven by Promising VERITAC-2 Trial Results and Strategic Partnership with Pfizer
2M ago
Hold Rating on Arvinas Holding Amid Uncertainties in Vepdegestrant’s Market Potential
PremiumRatingsHold Rating on Arvinas Holding Amid Uncertainties in Vepdegestrant’s Market Potential
2M ago
Arvinas downgraded to Market Perform from Outperform at Leerink
Premium
The Fly
Arvinas downgraded to Market Perform from Outperform at Leerink
2M ago
Arvinas, Pfizer announce VERITAC-2 trial did not reach statistical significance
Premium
The Fly
Arvinas, Pfizer announce VERITAC-2 trial did not reach statistical significance
2M ago
Arvinas downgraded to Hold from Buy at Truist
PremiumThe FlyArvinas downgraded to Hold from Buy at Truist
3M ago
Arvinas Earnings Call: Clinical Progress and Strategic Shifts
Premium
Company Announcements
Arvinas Earnings Call: Clinical Progress and Strategic Shifts
3M ago
Arvinas price target lowered to $10 from $20 at BMO Capital
Premium
The Fly
Arvinas price target lowered to $10 from $20 at BMO Capital
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100